Related Experiment Videos
Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide
V Srinivasan1, D Wielbo, J Simpkins
1Department of Pharmaceutics, University of Florida, Gainesville 32610, USA.
Pharmaceutical Research
|February 1, 1996
Summary
Codeine 6-glucuronide offers pain relief with reduced immunosuppression compared to codeine. This finding suggests potential benefits for pain management in immunocompromised patients.
Area of Science:
- Pharmacology
- Immunology
- Medicinal Chemistry
Background:
- Codeine is a widely used analgesic with known immunosuppressive side effects.
- Understanding the properties of codeine metabolites is crucial for developing safer analgesics.
Purpose of the Study:
- To evaluate the antinociceptive and immunosuppressive effects of codeine and its metabolite, codeine 6-glucuronide.
- To compare the efficacy and safety profiles of codeine and codeine 6-glucuronide in a rat model.
Main Methods:
- Codeine 6-glucuronide was synthesized and tested alongside a synthetic intermediate and morphine (positive control).
- Intracerebroventricular administration was used in rats.
- The tail flick model assessed antinociceptive responses.
- In vitro assays evaluated immunosuppressive effects.
Main Results:
- Both codeine and codeine 6-glucuronide demonstrated significant analgesic effects in the tail flick test.
- Codeine 6-glucuronide exhibited markedly lower immunosuppressive activity compared to codeine in vitro.
- The lipophilic intermediate also showed analgesic properties.
Conclusions:
- Codeine 6-glucuronide possesses potent antinociceptive properties with a potentially improved safety profile regarding immunosuppression.
- These findings suggest that codeine 6-glucuronide and related compounds could be valuable therapeutic options for pain management, particularly in immunocompromised individuals.